These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1427450)

  • 1. Alpha-interferon treatment of hairy cell leukemia and associated monoclonal large granular lymphocyte proliferation.
    Sgarabotto D; Zerbinati P; Vianello F; Valeri P; Girolami A; Dazzi F
    Haematologica; 1992; 77(4):367-8. PubMed ID: 1427450
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultrastructural, immunologic and clinical follow-up of five patients with HCL treated with interferon (IFN) for more than three years.
    Mantovani G; Astara G; Curreli L; Lai P; Turnu E; Locci F; Lantini MS; Cossu M; Riva A; Del Giacco GS
    Haematologica; 1992; 77(4):326-35. PubMed ID: 1427443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleural involvement in hairy cell leukemia response to recombinant interferon-alpha.
    Raffi F; Magadur G; Fiche M; Merrien D; Barrier JH; Grolleau JY
    Chest; 1990 Dec; 98(6):1544. PubMed ID: 2245718
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective myeloid aplasia: a long-lasting presentation of an unusual hairy cell leukemia variant?
    Marinone GM; Roncoli B
    Haematologica; 1993; 78(4):239-41. PubMed ID: 8294056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
    Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha interferon in the treatment of hairy cell leukemia.
    Tambone Reyes M; Gebbia V; Teresi M; Bonaccorso R; Colucci A; Quartararo L; Di Marco P; Citarrella P; Mansueto S
    J Chemother; 1989 Jul; 1(4 Suppl):1264-5. PubMed ID: 16312859
    [No Abstract]   [Full Text] [Related]  

  • 7. Genotypic and phenotypic evidence of T-cell leukemia in a patient successfully treated by interferon-alpha for typical hairy cell leukemia.
    Knecht H; Sarraj A; Delacrétaz F; Bachmann E; Clément F
    Leukemia; 1991 Dec; 5(12):1031-6. PubMed ID: 1663564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical evaluation of hairy cell leukemia.
    Demeter J; Porzsolt F
    Blood; 1992 Apr; 79(8):2171-3. PubMed ID: 1510754
    [No Abstract]   [Full Text] [Related]  

  • 9. More on paraproteinemia and hairy cell leukemia.
    Spector N; Pulcheri W; Nucci M; de Oliveira HP
    Haematologica; 1992; 77(1):99-100. PubMed ID: 1398294
    [No Abstract]   [Full Text] [Related]  

  • 10. Three years' continuous low-dose interferon-alpha treatment of hairy-cell leukemia: evaluation of response and maintenance dose.
    Goldmann B; Sonnen R; Kuse R
    Eur J Haematol; 1993 Sep; 51(3):177-8. PubMed ID: 8405334
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal expansion of large granular lymphocytes with a CD4+ CD8dim+/- phenotype associated with hairy cell leukemia.
    Airò P; Rossi G; Facchetti F; Marocolo D; Garza L; Lanfranchi A; Prati E; Brugnoni D; Malacarne F; Cattaneo R
    Haematologica; 1995; 80(2):146-9. PubMed ID: 7543070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of bone marrow changes during the treatment of hairy cell leukemia with interferon alpha.
    Flandrin G; Sigaux F; Castaigne S; Degos L
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():17-22. PubMed ID: 3833326
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced bone marrow colony growth in hairy-cell leukemia before and after interferon-alpha treatment. Possible inhibitory role of a serological factor.
    Lauria F; Bagnara GP; Guarini A; Catani L; Gaggioli L; Gugliotta L; Raspadori D; Macchi S; Zauli G; Zinzani PL
    Haematologica; 1988; 73(3):191-4. PubMed ID: 3139514
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leukaemia.
    Spielberger RT; Dickstein JI; Le Beau MM; Larson RA; Daly KM; Vardiman JW; Golomb HM
    Br J Haematol; 1993 Mar; 83(3):519-20. PubMed ID: 8485059
    [No Abstract]   [Full Text] [Related]  

  • 15. [Patient with decreased energy, dyspnea on exertion and splenomegaly].
    Hill W; Greither L; Bartl R; Jehn U; Kolb HJ; Wilmanns W
    Internist (Berl); 1991 Mar; 32(3):154-7. PubMed ID: 2055687
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha interferon as first line therapy for angioimmunoblastic lymphoadenopathy. Possible value of DR+ cells in monitoring therapeutical response.
    Milone G; Guglielmo P; Cacciola E; Calogero D; Giustolisi R
    Haematologica; 1992; 77(6):524-5. PubMed ID: 1289192
    [No Abstract]   [Full Text] [Related]  

  • 17. Regression of diffuse osteosclerosis in hairy cell leukaemia after treatment with interferon.
    Verhoef GE; De Wolf-Peeters C; Zachee P; Boogaerts MA
    Br J Haematol; 1990 Sep; 76(1):150-1. PubMed ID: 2223637
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological effects of interferons and their role in onco-hematological conditions.
    Agostini C; Pizzolo G; Semenzato G
    Allergol Immunopathol (Madr); 1991; 19(5):187-93. PubMed ID: 1725840
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in peripheral blood and bone marrow specimens following therapy with recombinant alpha 2 interferon for hairy cell leukemia.
    Bardawil RG; Groves C; Ratain MJ; Golomb HM; Vardiman JW
    Am J Clin Pathol; 1986 Feb; 85(2):194-201. PubMed ID: 3946302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyserythropoietic changes and sideroblastic anemia in patients with hairy cell leukemia before and after therapy with 2-chlorodeoxyadenosine.
    Zák P; Chrobák L; Podzimek K; Plísková L; Dedic K
    Neoplasma; 1998; 45(4):261-5. PubMed ID: 9890671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.